Evidence map›Paper›PMID 21575204›Full record

ArticleBMC cell biology2011

AGE-BSA down-regulates endothelial connexin43 gap junctions.

Chi-Young Wang, Hung-Jen Liu, Heng-Ju Chen, Yi-Chun Lin, Hsueh-Hsiao Wang, Ta-Chuan Hung, Hung-I Yeh

Open access · goldAbstract read
In one paragraph

Article in BMC cell biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2021
    Article
  7. p38 MAPK Pathway in the Heart: New Insights in Health and Disease.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Connexin channel and its role in diabetic retinopathy.Progress in retinal and eye research · 2017
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Chi-Young WangDepartment of Internal Medicine, Mackay Memorial Hospital, New Taipei City 251, Taiwan.
Hung-Jen Liu
Heng-Ju Chen
Yi-Chun Lin
Hsueh-Hsiao Wang
Ta-Chuan Hung
Hung-I Yeh
Mackay Memorial Hospital · TWNational Chung Hsing University · TWMackay Junior College of Medicine, Nursing and Management · TWMackay Medical College · TWNational Pingtung University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvanced glycation end products generated in the circulation of diabetic patients were reported to affect the function of vascular wall. We examined the effects of advanced glycation end products-bovine serum albumin (AGE-BSA) on endothelial connexin43 (Cx43) expression and gap-junction communication.

resultsIn human aortic endothelial cells (HAEC) treated with a series concentrations of AGE-BSA (0-500 μg/ml) for 24 and 48 hours, Cx43 transcript and Cx43 protein were reduced in a dose dependent manner. In addition, gap-junction communication was reduced. To clarify the mechanisms underlying the down-regulation, MAPKs pathways in HAEC were examined. Both a MEK1 inhibitor (PD98059) and a p38 MAPK inhibitor (SB203580) significantly reversed the reductions of Cx43 mRNA and protein induced by AGE-BSA. Consistently, phosphorylation of ERK and p38 MAPK was enhanced in response to exposure to AGE-BSA. However, all reversions of down-regulated Cx43 by inhibitors did not restore the functional gap-junction communication.

conclusionsAGE-BSA down-regulated Cx43 expression in HAEC, mainly through reduced Cx43 transcription, and the process involved activation of ERK and p38 MAPK.

Indexed as

AnimalsCattleCells, CulturedConnexin 43Down-RegulationEndothelial CellsFlavonoidsGap JunctionsGlycation End Products, AdvancedHumansImidazolesMAP Kinase Kinase 1p38 Mitogen-Activated Protein KinasesPhosphorylationPyridinesSerum Albumin, Bovine2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneConnexin 43FlavonoidsGlycation End Products, AdvancedImidazolesMAP Kinase Kinase 1p38 Mitogen-Activated Protein KinasesPyridinesSB 203580Serum Albumin, Bovine

Identifiers

PMID21575204
PMCPMC3224147
OpenAlexW2119076122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.